Elevate Clinical Research, Inc. — Form D

Elevate Clinical Research, Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-17. $1.0M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2026-02-17
• Form: D
• Accession: 0002105683-26-000001
• Industry: Other Health Care
• Exemptions: 06b
• Amount sold: $1.0M
• Minimum investment: $5K
• Investors: 7
• Date of first sale: 2025-06-01
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-573668

Issuer

• Name: Elevate Clinical Research, Inc.
• CIK: 0002105683
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2024
• Address: 211 E 7TH STREET, AUSTIN, TX, 78701
• Phone: 832-457-2167

Officers, directors & promoters (3)

More

• CIK 2105683 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search